QNG1
Queuosine 5'-phosphate N-glycosylase/hydrolase
Also known as: C9orf64, MGC10999, QNG1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T6V5
- Gene
- QNG1
- Ensembl
- ENSG00000165118
- Chromosome
- 9
- Canonical length
- 341 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Predicted to enable hydrolase activity. Involved in nucleoside salvage. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
341 residues, UniProt reviewed canonical sequence.
>Q5T6V5|QNG1
1 MDGLLNPRES SKFIAENSRD VFIDSGGVRR VAELLLAKAA GPELRVEGWK ALHELNPRAA
61 DEAAVNWVFV TDTLNFSFWS EQDEHKCVVR YRGKTYSGYW SLCAAVNRAL DEGIPITSAS
121 YYATVTLDQV RNILRSDTDV SMPLVEERHR ILNETGKILL EKFGGSFLNC VRESENSAQK
181 LMHLVVESFP SYRDVTLFEG KRVSFYKRAQ ILVADTWSVL EGKGDGCFKD ISSITMFADY
241 RLPQVLAHLG ALKYSDDLLK KLLKGEMLSY GDRQEVEIRG CSLWCVELIR DCLLELIEQK
301 GEKPNGEINS ILLDYYLWDY AHDHREDMKG IPFHRIRCIY YLocalizationUniProt · AlphaFold · HPA
Whether an antibody against QNG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- liver: 23 nTPM
- duodenum: 22 nTPM
- small intestine: 21 nTPM
- thyroid gland: 15 nTPM
- parathyroid gland: 13 nTPM
- kidney: 13 nTPM
Single-cell type
- hepatocytes: 30 nCPM
- extravillous trophoblasts: 28 nCPM
- enterocytes: 22 nCPM
- foveolar cells: 22 nCPM
- adrenal medulla cells: 21 nCPM
- alveolar cells type 1: 20 nCPM
Immune cell
- non-classical monocyte: 13 nTPM
- NK-cell: 13 nTPM
- myeloid DC: 12 nTPM
- intermediate monocyte: 12 nTPM
- classical monocyte: 10 nTPM
- eosinophil: 9.8 nTPM
Brain region
- choroid plexus: 24 nTPM
- white matter: 14 nTPM
- midbrain: 13 nTPM
- hypothalamus: 13 nTPM
- cerebral cortex: 13 nTPM
- medulla oblongata: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- nucleoside salvage
- tRNA modification
- tRNA queuosine(34) biosynthetic process from salvaged queuosine or its precursors
- purine nucleobase salvage
Molecular functions
- hydrolase activity
- queuosine nucleosidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Queuosine salvage protein family
- Queuosine salvage protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads QNG1 as an antibody target. Whether an autoantibody or antibody against QNG1 could matter depends on whether native QNG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
QNG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label QNG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...